VA SB1415 | 2023 | Regular Session

Status

Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on March 26 2023 - 100% progression
Action: 2023-03-26 - Governor: Acts of Assembly Chapter text (CHAP0631)
Text: Latest bill text (Chaptered) [HTML]

Summary

Opioid impact reduction. Allows any person to possess and administer naloxone or other opioid antagonist used for overdose reversal other than naloxone in an injectable formulation with a hypodermic needle or syringe in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health, provided that certain other conditions enumerated in current law are met. The bill removes training requirements related to the possession and administration of naloxone. The bill directs the Department of Health, the Department of Behavioral Health and Developmental Services, and the Department of Corrections to collaborate to develop a statewide comprehensive plan for the distribution of naloxone throughout the Commonwealth and allows such agencies to begin implementation of the plan to the extent the agencies are able to do so with existing resources. The bill requires the Department of Health to provide a report on the development of the comprehensive statewide naloxone plan, including the resources needed to fully implement the plan, to the Chairs of the House Committee on Appropriations and the Senate Committee on Finance and Appropriations by September 1, 2023. The bill directs the Department of Health to begin the development of a Commonwealth opioid impact reduction registry consisting of nonprofit organizations that work to reduce the impact of opioids in the Commonwealth and directs the Department of Corrections to amend its regulations to require that training in the administration of naloxone be provided to every inmate prior to release. Opioid impact reduction. Allows any person to possess and administer naloxone or other opioid antagonist used for overdose reversal other than naloxone in an injectable formulation with a hypodermic needle or syringe in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health, provided that certain other conditions enumerated in current law are met. The bill removes training requirements related to the possession and administration of naloxone. The bill directs the Department of Health, the Department of Behavioral Health and Developmental Services, and the Department of Corrections to collaborate to develop a statewide comprehensive plan for the distribution of naloxone throughout the Commonwealth and allows such agencies to begin implementation of the plan to the extent the agencies are able to do so with existing resources. The bill requires the Department of Health to provide a report on the development of the comprehensive statewide naloxone plan, including the resources needed to fully implement the plan, to the Chairs of the House Committee on Appropriations and the Senate Committee on Finance and Appropriations by September 1, 2023. The bill directs the Department of Health to begin the development of a Commonwealth opioid impact reduction registry consisting of nonprofit organizations that work to reduce the impact of opioids in the Commonwealth and directs the Department of Corrections to amend its regulations to require that training in the administration of naloxone be provided to every inmate prior to release.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Opioids; impact reduction registry, report.

Sponsors


Roll Calls

2023-02-20 - House - House: VOTE: Block Vote Passage (99-Y 0-N) (Y: 99 N: 0 NV: 0 Abs: 1) [PASS]
2023-02-15 - House - House: Reported from Appropriations (22-Y 0-N) (Y: 22 N: 0 NV: 0 Abs: 0) [PASS]
2023-02-14 - House - House: Reported from Health, Welfare and Institutions (21-Y 0-N) (Y: 21 N: 0 NV: 0 Abs: 1) [PASS]
2023-02-14 - House - House: Subcommittee recommends reporting (6-Y 0-N) (Y: 6 N: 0 NV: 0 Abs: 0) [PASS]
2023-02-02 - Senate - Senate: Passed Senate (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2023-02-02 - Senate - Senate: Constitutional reading dispensed (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2023-02-01 - Senate - Senate: Constitutional reading dispensed (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2023-01-31 - Senate - Senate: Reported from Finance and Appropriations with substitute (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
2023-01-19 - Senate - Senate: Reported from Education and Health with amendments (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2023-03-26 Governor: Acts of Assembly Chapter text (CHAP0631)
2023-03-26 Governor: Approved by Governor-Chapter 631 (effective 7/1/23)
2023-03-02 Governor: Governor's Action Deadline 11:59 p.m., March 27, 2023
2023-03-02SenateEnrolled Bill Communicated to Governor on March 2, 2023
2023-02-25SenateSigned by President
2023-02-23HouseSigned by Speaker
2023-02-23SenateBill text as passed Senate and House (SB1415ER)
2023-02-23SenateEnrolled
2023-02-20HouseVOTE: Block Vote Passage (99-Y 0-N)
2023-02-20HousePassed House BLOCK VOTE (99-Y 0-N)
2023-02-20HouseRead third time
2023-02-17HouseRead second time
2023-02-15HouseReported from Appropriations (22-Y 0-N)
2023-02-14HouseReferred to Committee on Appropriations
2023-02-14HouseReported from Health, Welfare and Institutions (21-Y 0-N)
2023-02-14HouseSubcommittee recommends referring to Committee on Appropriations
2023-02-14HouseSubcommittee recommends reporting (6-Y 0-N)
2023-02-13HouseAssigned HWI sub: Subcommittee #3
2023-02-13HouseReferred to Committee on Health, Welfare and Institutions
2023-02-13HouseRead first time
2023-02-13HousePlaced on Calendar
2023-02-02SenatePassed Senate (40-Y 0-N)
2023-02-02SenateConstitutional reading dispensed (40-Y 0-N)
2023-02-02SenateEngrossed by Senate - committee substitute SB1415S1
2023-02-02SenateCommittee substitute agreed to 23105909D-S1
2023-02-02SenateReading of substitute waived
2023-02-02SenateEducation and Health Committee amendments rejected
2023-02-02SenateRead second time
2023-02-01SenateConstitutional reading dispensed (40-Y 0-N)
2023-01-31SenateCommittee substitute printed 23105909D-S1
2023-01-31SenateReported from Finance and Appropriations with substitute (15-Y 0-N)
2023-01-19SenateRereferred to Finance and Appropriations
2023-01-19SenateReported from Education and Health with amendments (15-Y 0-N)
2023-01-13SenateAssigned Education sub: Health
2023-01-11SenateReferred to Committee on Education and Health
2023-01-11SenatePrefiled and ordered printed; offered 01/11/23 23101946D

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
32123.7(n/a)See Bill Text
5413408(n/a)See Bill Text

Virginia State Sources

TypeSource
Summaryhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+sum+SB1415
Texthttps://lis.virginia.gov/cgi-bin/legp604.exe?231+ful+SB1415+hil
Texthttps://lis.virginia.gov/cgi-bin/legp604.exe?231+ful+SB1415S1+hil
Texthttps://lis.virginia.gov/cgi-bin/legp604.exe?231+ful+SB1415ER+hil
Texthttps://lis.virginia.gov/cgi-bin/legp604.exe?231+ful+CHAP0631+hil
Amendmenthttps://committees.lis.virginia.gov/pdfs/drafts/23104719A.pdf
Amendmenthttps://lis.virginia.gov/cgi-bin/legp604.exe?231+amd+SB1415AS
Amendmenthttps://committees.lis.virginia.gov/pdfs/drafts/23105909D.pdf
Amendmenthttps://lis.virginia.gov/cgi-bin/legp604.exe?231+amd+SB1415ASR
Supplementhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+oth+SB1415F122+PDF
Supplementhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+oth+SB1415FS1122+PDF
Supplementhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+oth+SB1415FER122+PDF
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+S04V0049+SB1415
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+S05V0161+SB1415
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+SV0193SB1415+SB1415
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+SV0209SB1415+SB1415
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+SV0210SB1415+SB1415
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+H1203V0060+SB1415
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+H12V0211+SB1415
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+H02V0216+SB1415
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?231+vot+HV2037+SB1415

Bill Comments

feedback